Isolated Hepatic Perfusion With 200 Mg Melphalan for Advanced Noncolorectal Liver Metastases

Annals of Surgical Oncology - United States
doi 10.1245/s10434-008-9881-6
Full Text
Abstract

Available in full text

Categories
OncologySurgery
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases

Transactions of the ... Meeting of the American Surgical Association
2006English

Increasing the Effective Concentration of Melphalan in Experimental Rat Liver Tumours: Comparison of Isolated Liver Perfusion and Hepatic Artery Infusion*

British Journal of Cancer
Cancer ResearchOncology
1991English

Chemosaturation With Percutaneous Hepatic Perfusion of Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A Single Center Experience

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2019English

Isolated Hepatic Perfusion as a Treatment for Uveal Melanoma Liver Metastases (The SCANDIUM Trial): Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2014English

Liver Resection for Hepatic Metastases From Adrenocortical Carcinoma

HPB
HepatologyGastroenterology
2006English

Successful Treatment of Multiple Liver Metastases by Liver Perfusion.

BMJ
1987English

Melphalan Tissue Concentrations in Patients Treated With Regional Isolated Perfusion for Melanoma of the Lower Limb

British Journal of Cancer
Cancer ResearchOncology
1994English

Multiple Myeloma: Comparison of Two Dose-Intensive Melphalan Regimens (100 vs 200 Mg/M2)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

Review of Regional Limb Perfusion With Melphalan for Malignant Melanoma

BMJ
1966English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy